Biotech · Private company
USWM, LLC (dba US WorldMeds)
Track this companyFree. Adds USWM, LLC (dba US WorldMeds) to your Dealase workspace and tells you when its record changes.
Clinical trials91 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- LofexidinePhase 3 · Opioid WithdrawalClinicalTrials.gov · fetched Nov 12, 2026
- Lofexidine HClPhase 3 · Opioid DependenceClinicalTrials.gov · fetched Nov 12, 2026
- Open Label Lofexidine HCLPhase 3 · Opioid DependenceClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 2 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 2 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Letetresgene autoleucelPhase 2 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- LofexidinePhase 2 · Opioid Withdrawal (Disorder)ClinicalTrials.gov · fetched Nov 12, 2026
- Lofexidine (granules for reconstitution)Phase 1 · Normal Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- LUCEMYRA (lofexidine) tabletsPhase 1 · Normal Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- LUCEMYRA (lofexidine) tabletsPhase 1 · Opioid Withdrawal (Disorder)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- Eflornithine (DFMO) for Ewing Sarcoma and OsteosarcomaPHASE2 · RECRUITING · started Jun 5, 2026ClinicalTrials.gov NCT07321912 · fetched Nov 12, 2026
- A Pharmacokinetic, Safety, and Tolerability Study of LUCEMYRA in the Treatment of Opioid Withdrawal Management in Adolescent SubjectsPHASE1 · WITHDRAWN · started Jun 1, 2025ClinicalTrials.gov NCT06711640 · fetched Nov 12, 2026
- Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in VeteransPHASE2 · COMPLETED · started Mar 9, 2021ClinicalTrials.gov NCT04360681 · fetched Nov 12, 2026
- A Study Evaluating the Relative Bioavailability of Lofexidine Granules for Reconstitution Compared to LUCEMYRA (Lofexidine) Tablets and the Effect of Food on the Bioavailability of the Lofexidine Granules for ReconstitutionPHASE1 · COMPLETED · started Feb 16, 2021ClinicalTrials.gov NCT04188730 · fetched Nov 12, 2026
- Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell LiposarcomaPHASE2 · COMPLETED · started Dec 31, 2019ClinicalTrials.gov NCT05993299 · fetched Nov 12, 2026
- Lofexidine for Adults Undergoing Lumbar Spine SurgeryPHASE4 · COMPLETED · started Sep 1, 2019ClinicalTrials.gov NCT04126083 · fetched Nov 12, 2026
- Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of WithdrawalPHASE2 · TERMINATED · started Aug 2, 2019ClinicalTrials.gov NCT04070157 · fetched Nov 12, 2026
- Open-Label, Safety Study of LofexidinePHASE3 · COMPLETED · started Feb 1, 2015ClinicalTrials.gov NCT02363998 · fetched Nov 12, 2026
- Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid WithdrawalPHASE3 · COMPLETED · started Jun 1, 2013ClinicalTrials.gov NCT01863186 · fetched Nov 12, 2026